St. Jude Children's Research Hospital Leads the Way in Paediatric Interventional Oncology with IASIOS Enrolment

St. Jude Children's Research Hospital takes a groundbreaking step in paediatric oncology by enrolling in the International Accreditation System for Interventional Oncology Services (IASIOS), becoming the first paediatric hospital to pursue this prestigious accreditation.

FOR IMMEDIATE RELEASE

Providing the highest standards of care in paediatric oncology has always been central to St. Jude Children's Research Hospital's mission. We are proud to announce that St. Jude has officially enrolled in the International Accreditation System for Interventional Oncology Services (IASIOS), reinforcing its commitment to excellence in interventional oncology (IO) treatments. As the first paediatric hospital to seek IASIOS accreditation, St. Jude is setting a new precedent in paediatric oncology and establishing a benchmark within the broader field of IO, pushing the boundaries of cancer care for children.
IASIOS offers healthcare institutions a framework to standardize patient pathways and implement measurable quality standards. As IO becomes recognized as the fourth pillar of cancer treatment, alongside surgery, radiation, and systemic therapies, it is essential for hospitals providing IO services to adhere to rigorous guidelines to guarantee safe and effective treatments.
By enrolling in the IASIOS program, St. Jude Children's Research Hospital demonstrates its dedication to offering paediatric patients the best possible care by internationally recognized best practices. The IASIOS standards are based on the CIRSE Quality Assurance Guidelines for Interventional Oncology, endorsed by the European Cancer Organisation (ECO) and supported by over 40 international medical societies.

Dr. Michael Temple, Director of Interventional Radiology in the Diagnostic Imaging Department at St. Jude, leads the accreditation effort. His endorsement of the hospital's decision to enrol in the program is a testament to the hospital's commitment to advancing safe, innovative interventional oncology treatments for children.

"At St Jude, we are focused on the development, assessment and promotion of paediatric interventional oncology procedures. Seeking IASIOS accreditation demonstrates to our young patients and their families, our commitment to providing the highest quality of clinical care."

As an IASIOS Enrolled Centre, St. Jude joins a global community of IO centres dedicated to advancing and promoting interventional oncology practices. This international network allows member facilities to collaborate, share knowledge, and participate in exclusive events, seminars, and workshops, all while working to raise awareness about the benefits of IO among patients and medical providers.

About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is transforming the understanding, treatment, and cure of childhood cancer, sickle cell disease, and other life-threatening disorders. As the only National Cancer Institute-designated Comprehensive Cancer Centre focused solely on children, St. Jude has been instrumental in significantly increasing the overall childhood cancer survival rate since its inception over sixty years ago. The hospital is dedicated to sharing its breakthroughs with doctors and researchers at local hospitals and cancer centres globally, enhancing the quality of treatment and care for even more children. To discover more about St. Jude's mission and innovations, visit www.stjude.org.

About IASIOS
The International Accreditation System for Interventional Oncology Services (IASIOS) is the first accreditation system designed for medical facilities operating in interventional oncology and aspiring for formal recognition. The global IASIOS accreditation streamlines the whole patient pathway and provides facilities with essential quality standards for safer procedures and patient satisfaction. Centres that are enrolled in the IASIOS system can utilise the support provided by the IASIOS office and optional consultancy while they are in the process of improving their IO service lines and preparing their IASIOS application. In addition to the accreditation, IASIOS is a membership programme providing a global network of like-minded interventional oncologists. For more information, please visit www.iasios.org

Neutorgasse 9, 1010 Vienna, Austria
Mardis Karlsdottir, COO of IASIOS
Email: office@iasios.org
Phone: +43 1 904 2003 57

IASIOS is a membership-based accreditation system specifically developed for medical facilities operating in interventional oncology and aspiring for formal recognition either as part of an existing institution or as an independent entity. Regardless of size and location, any facility that wishes to obtain accreditation for its IO service line can apply.

This global accreditation system, operated by the Interventional Radiology Accreditation Service GmbH (IRAS), is intended to establish the highest standards for patient care in interventional oncology (IO) and encourage good practice in IO. IASIOS provides facilities with a unique opportunity to showcase their achievements and gain recognition for their IO services.

IASIOS is based on the CIRSE Standards of Quality Assurance in Interventional Oncology, a comprehensive quality assurance document developed by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). It looks at the whole patient care and treatment process and what is required to deliver IO services as a primary clinical caregiver. By featuring clearly outlined requirements, it functions as a framework for developing and implementing wider measures for safe and efficient IO practice along the entire patient pathway. The document has received broad international support from national and international societies and the European Cancer Organisation.

This release was published on openPR.